$SRNE I believe today was the official announcement that Sorrento have now completed all the legwork for researching, licensing and acquiring strong potential solutions to battle COVID-19 on all fronts. Hence his message in the last piece of PR yesterday... Dr. Henry Ji, Chairman and CEO of Sorrento stated, “Stem cells were a missing piece in our comprehensive portfolio of potential solutions against COVID-19. We now cover multiple stages of the continuum of care from prevention to potential therapeutic solutions for the most advanced stages of the disease. He had always mentioned we are an R&D company and this is what we do best. Manufacturing is also set and ready to go. Sorrento could very well be the next acquisition target on big pharma's list. An all in one package with one price tag. No stress.
  • 15
15 Likes